🔎 Trials Near Me

Home › Thyroid Cancer

Thyroid Cancer clinical trials recruiting in the U.S.

51 studies for Thyroid Cancer are recruiting participants at sites across the United States.

Your thyroid is a butterfly-shaped gland in your neck. There are several thyroid cancer types with different treatments. Discover options available.

Cities with the most studies

By state

Recently updated studies

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06902376

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

RecruitingPhase 2
Ages 18 to 98 · All sexes · Updated Oct 5, 2026 · NCT04927416

DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study

RecruitingObservational studyHealthy volunteers welcome
1 Month – 99 Years · All sexes · Updated Oct 2, 2026 · NCT01247597

Studies on Tumors of the Thyroid

RecruitingObservational study
6 Months – 98 Years · All sexes · Updated Oct 2, 2026 · NCT00001160

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

DESTINY-PANTUMOUR04

RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

RecruitingObservational study
Ages 4 and older · All sexes · Updated Sep 22, 2026 · NCT01005654

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05786924

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

Recruiting
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07218315

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT03647358

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

RecruitingPhase 2
Ages 18 to 90 · All sexes · Updated Sep 9, 2026 · NCT03841617

Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06959511

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Recruiting
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT07225309

Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT03099356

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

RecruitingPhase 2
Ages 2 to 25 · All sexes · Updated Jul 24, 2026 · NCT06458036

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

Recruiting
Ages 21 to 45 · All sexes · Updated Jul 6, 2026 · NCT07406087

Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jun 30, 2026 · NCT04892303

Integrated Cancer Repository for Cancer Research

RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699

A Study of Avutometinib and Defactinib in People With Thyroid Cancer

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT06007924

Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer

RecruitingPhase 2
Ages 13 and older · All sexes · Updated Jun 18, 2026 · NCT06961084

Environmental Factors and Thyroid Cancer

RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT05172921

Hereditary Risk Factors for Thyroid Cancer

RecruitingHealthy volunteers welcome
All ages · All sexes · Updated Jun 11, 2026 · NCT02747888

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.